The cholesterol-lowering effect upon ASGR1 deficiency could be attributed to several factors such as reduction of intestinal absorption, de novo hepatic cholesterol synthesis, VLDL secretion, or increase of clearance by tissue uptake, as well as obesity. Here, ASGR1 is linked to obesity due to melanocortin 4 receptor deficiency.